½ÃÀ庸°í¼­
»óǰÄÚµå
1419129

¼¼°è µðÁöÅÐ ¾à±¹ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® - º¸°í¼­ ¹üÀ§ : ¾àÁ¦ À¯Çüº°, Á¦Ç°º°, Ç÷§Æûº°, Áö¿ªº°

Digital Pharmacy Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Type, Product, Platform, and Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐ ¾à±¹ ½ÃÀåÀº 2022³â 964¾ï 2,800¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 3,638¾ï 7,800¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022-2030³â°£ CAGRÀº 18.1%·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

COVID-19 ÆÒµ¥¹Í½Ã 󹿾àÀÇ ¿Â¶óÀÎ ±¸¸Å ±ÞÁõ°ú ¿Â¶óÀÎ Ç÷§ÆûÀ¸·ÎÀÇ °æ»ç Áõ°¡´Â µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¸î °¡Áö ¿äÀÎÀÔ´Ï´Ù.

µðÁöÅÐ ¾à±¹À̶õ ÇÏÀÌÅ×Å©¿Í È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» °³ÀÎÀûÀÎ ÅÍÄ¡·Î °áÇÕÇÏ¿© ½Å±Ô, ±âÁ¸, µðÁöÅÐ Ä¡·áÀÇ »óǰȭ¸¦ Áö¿øÇÏ´Â »ç¾÷ü¸¦ Ä¿¹öÇÏ´Â Çã°¡ ¾à±¹À» ¸»ÇÕ´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº ó¹æÀüÀ» ÀÛ¼ºÇÏ´Â °úÁ¤À» °£¼ÒÈ­Çϰí ÀÌÇØ°ü°èÀÚÀÇ °æÇèÀ» °³¼±ÇÏ¸ç ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¾÷ü¿¡°Ô ½Ç¿ëÀûÀÎ ÅëÂû·ÂÀ¸·Î ó¹æÀü ¿©ÇàÀ» ¸íÈ®È÷ ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, µðÁöÅÐ ¾à±¹Àº ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¾÷ü°¡ À庮À» Á¦°ÅÇϰí Á¦¾à ¾à±¹ÀÌ ±ú²ýÇϰí Áï½Ã Á¶Á¦ÇÒ ¼ö Àִ ó¹æÀüÀ» ¹ÞÀ» ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.

½ÃÀå µ¿Çâ

Çõ½ÅÀûÀÎ ÀüÀÚ ¾à±¹ ¸ðµ¨

SHOPS Ç÷¯½º°¡ 2019³â 12¿ù ¹ßÇ¥ÇÑ º¸°í¼­ ¡°¹Î°£ ºÎ¹®(SHOPS) Ç÷¯½º¿¡ ÀÇÇÑ °Ç°­ ¼º°ú Áö¼Ó¡±¿¡ µû¸£¸é

ÀεµÀÇ ÇÁ·ÎÁ§Æ® ÆÀÀº ¸Þµð¾Æ ÇÁ¶óµ¥½Ã ÁÖ Á¤ºÎ ¹× Á¦¾à ȸ»ç ¸Þµå ¶óÀÌÇÁ ÀÎÅͳ»¼Å³Î°úÀÇ Á¦ÈÞ¸¦ ¹ßÇ¥ÇÏ°í °áÇÙ ´ëÃ¥À¸·Î Çõ½ÅÀûÀÎ ¾àÁ¦¿¡¼­ ÃâÀÔ±¸±îÁö ÀüÀÚ ¾à±¹ ¸ðµ¨À» ½ÃÀÛÇß½À´Ï´Ù. SHOPS Plus Prohect ÆÀÀº ÀüÀÚ ¾à±¹ ¸ðµ¨/Ç÷§ÆûÀ» ÅëÇØ °áÇÙ ¼­ºñ½º¸¦ °­È­ÇÏ´Â ¼­ºñ½º Á¦°ø ¸ðµ¨À» ¼³°èÇß½À´Ï´Ù. ¿¹¸¦ µé¾î Àεµ¿¡¼­´Â °áÇÙÀÇ À¯ÇàÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ³ª¶ó´Â ¿©ÀüÈ÷ °¡Àå ¸¹Àº °áÇ٠ȯÀÚ¸¦ º¸À¯Çϰí ÀÖÀ¸¸ç ¿¬°£ 50¸¸ °ÇÀÌ Áø´ÜµÇÁö ¾ÊÀº »óÅ·Π³²¾Æ ÀÖ½À´Ï´Ù. µû¶ó¼­ SHOP Plus´Â ±â¼úÀ» Ȱ¿ëÇϰí ÀüÀÚ ¾à±¹ ¸ðµ¨À» ÅëÇØ ȯÀÚÀÇ ´« ¾Õ¿¡¼­ Áø´Ü ¹× Ä¡·á Áö¿ø ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. SHOP Ç÷¯½º¿¡ ÀÇÇÑ ÀÌ·¯ÇÑ ³ë·ÂÀº ȯÀÚÀÇ °áÇÙ ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»ó¿¡ ±â¿©ÇÕ´Ï´Ù. SHOP Ç÷¯½º ÇÁ·ÎÁ§Æ®°¡ ¼³°èÇÑ e-pharmacy Ç÷§ÆûÀ» »ç¿ëÇÏ¸é °áÇ٠ȯÀÚ¿ë ÀçÅà °´´ã °Ë»ç Àç·á¸¦ ó¹æÇÒ ¼ö ÀÖÀ¸¸ç °Ë»ç´Â ¿ø°Ý Á¶ÀÛÀ¸·Î ¿Ï·áµË´Ï´Ù. e-pharmacy ¿¡ÀÌÀüÆ®°¡ Àç·á¸¦ ¹Þ°í °Ë»ç ½Ã¼³¿¡ Àü´ÞÇÕ´Ï´Ù. °´´ã Àç·á¸¦ ó¸®ÇÑ ÈÄ, ½ÇÇè½ÇÀº ȯÀÚÀÇ °Ë»ç º¸°í¼­¸¦ e-pharmacy Ç÷§Æû¿¡ ¾÷·ÎµåÇÕ´Ï´Ù. °áÇ٠ȯÀÚ´Â º¸°í¼­¸¦ º¼ ¼ö ÀÖÀ¸¸ç ÀÇ»ç´Â ȯÀÚ¿¡°Ô Ä¡·á¹ýÀ» ó¹æ ÇÒ ¼ö ÀÖ½À´Ï´Ù. e-pharmacy Ç÷§ÆûÀº ȯÀÚÀÇ Ä¡·á ¾îµåÈ÷¾î·±½º¿Í ÇâÈÄ ÁÖ¹®À» ÈļÓÇÏ´Â Ä¿¹Â´ÏÄÉÀÌ¼Ç ±â¼úµµ °®Ãß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ e-pharmacy ¸ðµ¨Àº ¿¹Ãø ±â°£ 2020-2030³â¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÃÀå µ¿Çâ

ÅëÇÕ À¥ ±â¹Ý ¿Â¶óÀÎ ¾à±¹ ÀÎÅÍÆäÀ̽º°¡ ÁÖ¿ä µ¿ÇâÀ¸·Î ºÎ»ó

¾à»ç¿Í ȯÀÚ°¡ ¾×¼¼½ºÇÒ ¼ö ÀÖ´Â À¥ ±â¹Ý ¾à±¹ ÀÎÅÍÆäÀ̽º¸¦ ÅëÇÕÇÑ ÅëÇÕ e-ÇコÄÉ¾î ½Ã½ºÅÛÀº ÇâÈÄ ¸î ³âµ¿¾È µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ »õ·Î¿î Ãß¼¼·Î ºÎ»óÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ÀǾàǰÀ» ±¸¸ÅÇÏ´Â »ç¶÷µé¿¡°Ô ¿Â¶óÀÎ Áö¿øÀ» Á¦°øÇϱâ À§ÇØ ¿Â¶óÀÎ ¾à±¹ÀÌ Á¦°øÇÏ´Â ÇÁ·Î±×·¥Àº ÀÌ·¯ÇÑ ÀÎÅÍÆäÀ̽ºÀÇ µÎµå·¯Áø ¿¹ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, Ä¡·áÀÇ ÀÏȯÀ¸·Î ½ºÅ¸Æ¾À» Åõ¿©¹ÞÀº ȯÀÚ´Â ¾à¹° º¹¿ëÀ» Áß´ÜÇϰųª ºÒ±ÔÄ¢ÇÑ ÇൿÀ» ÃëÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ½ºÅ¸Æ¾À» ±â¹ÝÀ¸·Î ó¹æµÈ ÀǾàǰÀ» º¹¿ëÇÏ´Â »ç¶÷µé¿¡°Ô ¾îµåÈ÷¾î·±½º Áö¿øÀ» Á¦°øÇÏ´Â ÈÆ·Ã¹ÞÀº ¾à±¹ ÆÀ¿ø°úÀÇ ¾Ë¸² ¹× ½Ç½Ã°£ äÆÃÀº º¹¿ë Áß´ÜÀ» ÇÇÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

Ç÷§Æû ±â¹Ý ÅëÂû·Â

Ç÷§Æû °üÁ¡¿¡¼­ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ¾Û ±â¹Ý°ú À¥»çÀÌÆ® ±â¹ÝÀ¸·Î ºÐ·ùµË´Ï´Ù. ¾Û ±â¹ÝÀº ¶ÇÇÑ ÅÚ·¹Çコ ¾à±¹ ¾Û, Åõ¾à °ü¸® ¾Û, °Ç°­¡¤À£ºù ¾Û, Á¦¾à ¾à±¹ ¾Û µîÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾Û ±â¹Ý ºÎ¹®Àº 2022³â¿¡ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È 17.60%ÀÇ ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÅÚ·¹Çコ ¾à±¹ ¾ÛÀº 2022-2030³â »çÀÌ¿¡ ¾Û ±â¹Ý ºÎ¹®¿¡¼­ ½ÃÀåÀÇ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¡»ó ÇコÄɾî´Â ÅÚ·¹Çコ ¾ÛÀ» ÅëÇØ ¾îµð¼­³ª ¾×¼¼½ºÇÒ ¼ö ÀÖ½À´Ï´Ù. 2021³â¿¡ ¹ßÇ¥µÈ CDCÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é, 2020³â¿¡´Â ¼ºÀÎÀÇ 37.0%°¡ Á¦°ø¾÷üÀÇ ¹æ¹®, ¿Â¶óÀΠó¹æ, Á¤½Å°Ç°­ ¼­ºñ½º¸¦ Æ÷ÇÔÇÑ ¿ø°Ý ÀǷḦ ÀÌ¿ëÇß½À´Ï´Ù. ÃÖ°íÀÇ ¿ø°Ý ÀÇ·á ¾ÛÀº ¹«·á·Î ´Ù¿î·Îµå ÇÒ ¼ö ÀÖÀ¸¸ç »ç¿ëÇϱ⠽±°í º¸Çè ¼­ºñ½º¸¦ ¿ÏÀüÈ÷ ´Ù·ç´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÅÚ·¹Çコ ¾à±¹ ¾ÛÀÇ ¸î °¡Áö ¿¹´Â Hims & Hers, GoodRx, K Health, Doctor on DemandÀÔ´Ï´Ù. GoodRx´Â Àú·ÅÇÑ ºñ¿ëÀÇ ¹æ¹®, ¿ìÆíÀ¸·Î °£´ÜÇÑ Ã³¹æÀü º¸Ãæ, °Ç°­ º¸ÇèÀÌ ¾ø´Â ¹æ¹® µîÀÇ ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.

¾àÁ¦ À¯Çüº°·Î µðÁöÅÐ ¾à±¹ ½ÃÀåÀº 󹿾à°ú ½ÃÆÇ¾àÀ¸·Î À̺е˴ϴÙ. 2022³â ½ÃÀå Á¡À¯À²Àº ÀÇ·á¿ë ÀǾàǰÀÌ Å©°í ¿¹Ãø ±â°£ Áß CAGRÀº 17.83%·Î ¿¹ÃøµË´Ï´Ù. µðÁöÅÐ ¾à±¹ ½ÃÀåÀº Á¦Ç°º°·Î °³ÀÎ °ü¸®, ºñŸ¹Î ¹× º¸ÃæÁ¦, ÀǾàǰ ¹× Ä¡·á ¹× ±âŸ Á¦Ç°À¸·Î ±¸ºÐµË´Ï´Ù. ÀǾàǰ ¹× Ä¡·á ºÎ¹®Àº ¶ÇÇÑ ¼º °Ç°­, ½Å°æ Àå¾Ö, ½ÉÀå °ü¸®, ´ç´¢º´, üÁß °¨¼Ò µîÀ¸·Î ºÐ·ùµË´Ï´Ù. ÀǾàǰ¡¤Ä¡·á ºÎ¹®Àº 2022³â¿¡ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß¿¡ 17.87%¶ó´Â ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. Ç÷§Æû °üÁ¡¿¡¼­ µðÁöÅÐ ¾à±¹ ½ÃÀåÀº ¾Û ±â¹Ý°ú À¥»çÀÌÆ® ±â¹ÝÀ¸·Î ºÐ·ùµË´Ï´Ù. ¾Û ±â¹ÝÀº ¶ÇÇÑ ÅÚ·¹Çコ ¾à±¹ ¾Û, Åõ¾à °ü¸® ¾Û, °Ç°­¡¤À£ºù ¾Û, Á¦¾à ¾à±¹ ¾Û µîÀ¸·Î ±¸ºÐµË´Ï´Ù. 2022³â ½ÃÀå Á¡À¯À²Àº ¾Û ±â¹ÝÀÌ Å©¸ç, ÀÌ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È 17.60%¶ó´Â ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ºº°¿¡¼­ ½ÃÀåÀº ³²¼º°ú ¿©¼ºÀ¸·Î À̺е˴ϴÙ. 2022³â ½ÃÀå Á¡À¯À²Àº ¿©¼ºÀÌ Å©°í ¿¹Ãø ±â°£ Áß CAGRÀº 17.64%·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå µðÁöÅÐ ¾à±¹ ½ÃÀåÀÇ Á¤¼¼

  • PEST ºÐ¼®
  • »ýÅÂ°è ºÐ¼®
    • ¹ë·ùüÀÎÀÇ º¥´õ À϶÷

Á¦5Àå µðÁöÅÐ ¾à±¹ ½ÃÀå - ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ÁÖ¿ä ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ÁÖ¿ä ½ÃÀå ±âȸ
  • ÇâÈÄÀÇ µ¿Çâ
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®

Á¦6Àå µðÁöÅÐ ¾à±¹ ½ÃÀå - ¼¼°è ½ÃÀå ºÐ¼®

  • µðÁöÅÐ ¾à±¹ ½ÃÀå : ¼¼°è ½ÃÀå °³¿ä
  • µðÁöÅÐ ¾à±¹ ¼¼°è ½ÃÀå°ú 2030³â±îÁöÀÇ ¿¹Ãø

Á¦7Àå µðÁöÅÐ ¾à±¹ ½ÃÀå : ¾àÁ¦ À¯Çüº° ¼öÀÍ ºÐ¼®(2020-2030³â)

  • 󹿾à
  • ½ÃÆÇ¾à

Á¦8Àå µðÁöÅÐ ¾à±¹ ½ÃÀå : Á¦Ç°º° ¼öÀÍ ºÐ¼®(2020-2030³â)

  • ÀǾàǰ
  • ÆÛ½º³ÎÄɾî
  • ºñŸ¹Î°ú º¸ÃæÁ¦
  • ±âŸ

Á¦9Àå µðÁöÅÐ ¾à±¹ ½ÃÀå : Ç÷§Æûº° ¼öÀÍ ºÐ¼®(2020-2030³â)

  • ¾Û
  • À¥»çÀÌÆ®

Á¦10Àå µðÁöÅÐ ¾à±¹ ½ÃÀå : Áö¿ªº° ¼öÀÍ ºÐ¼®(2020-2030³â)

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ¿µ±¹
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • È£ÁÖ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • Áß³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ Áß³²¹Ì

Á¦11Àå COVID-19 ÀüÈÄÀÇ ¿µÇâ

Á¦12Àå ¾÷°è Á¤¼¼

  • ÇÕº´°ú Àμö
  • °è¾à, Á¦ÈÞ, ÇÕÀÛ »ç¾÷
  • ½ÅÁ¦Ç° Ãâ½Ã
  • »ç¾÷ È®´ë ¹× ±âŸ Àü·«Àû Àü°³

Á¦13Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷ÀÇ È÷Æ®¸Ê ºÐ¼®
  • ±â¾÷ÀÇ Æ÷Áö¼Å´×°ú ÁýÁßµµ

Á¦14Àå µðÁöÅÐ ¾à±¹ ½ÃÀå - ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Alto
  • PillPak
  • Capsule
  • CVS Health
  • Cigna
  • Walgreen Co.
  • Walmart Inc.
  • Amazon.com, Inc.
  • The Kroger Co.
  • GoodRx

Á¦15Àå ºÎ·Ï

JHS 24.02.14

The digital pharmacy market is expected to grow from US$ 96.428 billion in 2022 to US$ 363.878 billion by 2030; it is expected to grow at a CAGR of 18.1% from 2022 to 2030.

Upsurge in online purchase of prescription medicines during the COVID-19 pandemic and an increasing inclination toward online platforms are a few factors driving the digital pharmacy market growth.

A digital pharmacy is a licensed pharmacy covering an entity combining high-tech and efficient solutions through a personal touch that helps commercialize new, existing, and digital therapies. The solution simplifies the process of filling a prescription, enhances stakeholders' experiences, and clarifies the prescription journey with actionable insights for biopharma manufacturers. For example, digital pharmacies can help biopharma companies remove barriers, enabling dispensing pharmacies to receive clean and ready-to-dispense prescriptions.

Market Trend

Innovative E-Pharmacy Model

According to the published report by SHOPS Plus in December 2019, Sustaining Health Outcomes through the Private Sector (SHOPS) Plus

The project team in India announced a partnership with the State Government of Madhya Pradesh and the pharmaceutical company Medlife International to launch an innovative, drug-to-doorstep e-pharmacy model to fight against tuberculosis (TB). The SHOPS Plus Prohect team designed the service delivery model to strengthen the TB services through an e-pharmacy model/platform. For example, in India, the TB epidemic is declining. However, the country still holds the most significant number of TB patients, with half a million cases carried undiagnosed annually. Therefore, SHOP Plus is working to utilize technology to provide diagnosis and treatment support services available at the patient's doorstep through an e-pharmacy model. Such initiatives by SHOP Plus will help to increase access to TB services among patients. With the e-pharmacy platform designed by the SHOP Plus project, TB patients can prescribe home sputum testing materials for TB patients, and the test is completed remotely. The e-pharmacy agent will pick up the material and deliver it to the lab facility. After processing the sputum material, the lab will upload the patient's testing report on the e-pharmacy platform. TB patients can view the report, and physicians can prescribe the treatment for the patient. The e-pharmacy platform also features communication technology to follow up with patients' treatment adherence and future orders. Such innovative e-pharmacy models will provide lucrative market opportunities for growth in the forecast period 2020-2030.

Market Trend

Integrated Web-Based Online Pharmacy Interface Emerges as Key Trend

Integrated e-healthcare systems incorporated with web-based pharmacy interfaces that are accessible to pharmacists and patients are likely to emerge as new trends in the digital pharmacy market in the coming years. Programs made available by online pharmacies to provide online support to people buying medicines are a notable example of such interfaces. For instance, patients administered with statins as a part of their treatments are likely to discontinue or show irregularities in taking medicines. Reminders and live chat with a pharmacy team member trained in providing adherence support to people consuming statin-based prescribed medicines can help avoid the discontinuation of doses.

Platform-Based Insights

In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. Telehealth pharmacy apps are expected to account for a maximum share of the market for the app-based segment during 2022-2030. Virtual healthcare can be accessed through telehealth apps from anywhere. According to CDC data published in 2021, 37.0% of adults used telemedicine in 2020, including provider visits, online prescriptions, and mental health services. The best telehealth apps can be downloaded free of cost and are easy to use, and they often completely cover insurance services. A few examples of telehealth pharmacy apps are Hims & Hers, GoodRx, K Health, and Doctor on Demand. GoodRx offers services such as low-cost visits, easy prescription refills via mail, and visits without health insurance.

Based on drug type, the digital pharmacy market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.83% during the forecast period. Based on product, the digital pharmacy market is segmented into personal care, vitamins & supplements, medicines & treatments, and other products. The medicine & treatments segment is further segregated as sexual health, neurological disorders, heart care, diabetes, weight loss, and others. The medicine and treatment segment held a larger market share in 2022, and the segment is anticipated to register a higher CAGR of 17.87% during the forecast period. In terms of platform, the digital pharmacy market is categorized into app-based and website-based. The app-based is further segmented into telehealth pharmacy apps, medication management apps, health and wellness apps, compounding pharmacy apps, and others. The app-based segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.60% during the forecast period. By gender, the market is bifurcated into males and females. The females segment held a larger market share in 2022, and the same segment is anticipated to register a higher CAGR of 17.64% during the forecast period.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Digital Pharmacy Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Digital Pharmacy Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Digital Pharmacy Market - Global Market Analysis

  • 6.1 Digital Pharmacy - Global Market Overview
  • 6.2 Digital Pharmacy - Global Market and Forecast to 2030

7. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Drug Type, 2020-2030

  • 7.1 Overview
  • 7.2 Prescription Medicines
  • 7.3 Over the Counter Products

8. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Products, 2020-2030

  • 8.1 Overview
  • 8.2 Medicine
  • 8.3 Personal Care
  • 8.4 Vitamins and Supplements
  • 8.5 Others

9. Digital Pharmacy Market - Revenue Analysis (USD Million) - By Platform, 2020-2030

  • 9.1 Overview
  • 9.2 Apps
  • 9.3 Websites

10. Digital Pharmacy Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Digital Pharmacy Market Overview
    • 10.1.2 North America Digital Pharmacy Market Revenue and Forecasts to 2030
    • 10.1.3 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Drug Type
    • 10.1.4 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Products
    • 10.1.5 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Platform
    • 10.1.6 North America Digital Pharmacy Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Digital Pharmacy Market
        • 10.1.6.1.1 United States Digital Pharmacy Market, by Drug Type
        • 10.1.6.1.2 United States Digital Pharmacy Market, by Products
        • 10.1.6.1.3 United States Digital Pharmacy Market, by Platform
      • 10.1.6.2 Canada Digital Pharmacy Market
        • 10.1.6.2.1 Canada Digital Pharmacy Market, by Drug Type
        • 10.1.6.2.2 Canada Digital Pharmacy Market, by Products
        • 10.1.6.2.3 Canada Digital Pharmacy Market, by Platform
      • 10.1.6.3 Mexico Digital Pharmacy Market
        • 10.1.6.3.1 Mexico Digital Pharmacy Market, by Drug Type
        • 10.1.6.3.2 Mexico Digital Pharmacy Market, by Products
        • 10.1.6.3.3 Mexico Digital Pharmacy Market, by Platform

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Digital Pharmacy Market - Key Company Profiles

  • 14.1 Alto
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 PillPak
  • 14.3 Capsule
  • 14.4 CVS Health
  • 14.5 Cigna
  • 14.6 Walgreen Co.
  • 14.7 Walmart Inc.
  • 14.8 Amazon.com, Inc.
  • 14.9 The Kroger Co.
  • 14.10 GoodRx

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦